Novartis drafts TV celeb Nick Cannon to talk up importance of flu vaccines

Tools
Nick Cannon

Novartis ($NVS) may be selling off most of its vaccines business to GlaxoSmithKline ($GSK), but for now, it's hanging onto its flu vaccines. And to help show Americans just how important those flu vaccines are, it's teamed up with entertainer Nick Cannon, who's advising consumers to prepare for flu season by getting their shots and stocking up on the Swiss pharma's over-the-counter remedy, Theraflu. More from FiercePharmaMarketing

Filed Under

Comments